ANAPTYSBIO INC
Profile
Company Names
ANAPTYSBIO INC
Addresses
10421 PACIFIC CENTER COURT, SUITE 200, SAN DIEGO, CA 92121
10835 ROAD TO THE CURE, SUITE 100, SAN DIEGO, CA 92121
Phone Numbers
858-362-6295
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2005
State Incorporated:
DELAWARE
Total Amount Raised:
$50,837,788.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2015-07-13
$40,767,277.00
$40,767,277.00
$0.00
Equity
4
2013-08-30
$2,022,117.00
$6,250,000.00
$4,227,883.00
Debt
3
2011-10-05
$8,024,394.00
$21,975,606.00
$13,951,212.00
Equity
2
2011-01-21
$14,400.00
$14,400.00
$0.00
Equity
1
2010-10-07
$9,600.00
$9,600.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIBA
AYNECHI
DIRECTOR
THESAN PHARMACEUTICALS, INC.
| IRHYTHM TECHNOLOGIES, INC.
| ANAPTYSBIO INC
| GENOA PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| ARCELLX, INC.
| NKARTA, INC.
| AVALYN PHARMA INC.
| SPRUCE BIOSCIENCES, INC.
| ARISTEA THERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
| REZO THERAPEUTICS, INC.
| RAY THERAPEUTICS, INC.
CAROL
GALLAGHER
DIRECTOR
CALISTOGA PHARMACEUTICALS INC
| ANAPTYSBIO INC
| ARAGON PHARMACEUTICALS, INC.
| ATTEROCOR, INC.
| SANTA MARIA BIOTHERAPEUTICS, INC.
| PINTA BIOTHERAPEUTICS, INC.
| NINA BIOTHERAPEUTICS, INC.
| CLEAVE BIOSCIENCES, INC.
| MILLENDO THERAPEUTICS, INC.
| METACRINE, INC.
| PIONYR IMMUNOTHERAPEUTICS, INC.
| ANNEXON, INC.
| QPEX BIOPHARMA, INC.
| CHROMACODE, INC.
| ASSABET VALLEY BANCORP
| TREX HOLDINGS INC.
| ONCORESPONSE, INC
ROBERT
HOFFMAN
EXECUTIVE OFFICER
KEVIN
KINSELLA
DIRECTOR
HEATH
LUKATCH
DIRECTOR
INOGEN INC
| ANAPTYSBIO INC
| CIANNA MEDICAL INC
| ELEVATION PHARMACEUTICALS INC
| FLEXION THERAPEUTICS INC
| SPINIFEX PHARMACEUTICALS INC
| SATSUMA PHARMACEUTICALS, INC.
| ADYNXX, INC.
| ENGAGE THERAPEUTICS, INC.
| VIEWPOINT THERAPEUTICS, INC.
| HALO NEURO INC.
| SUTROVAX, INC.
| VIACYTE INC.
| CARGO THERAPEUTICS, INC.
| MAGNUS MEDICAL, INC.
JOHN
SCHMID
DIRECTOR
JAMES
TOPPER
DIRECTOR
CALISTOGA PHARMACEUTICALS INC
| INCLINE THERAPEUTICS, INC.
| PORTOLA PHARMACEUTICALS INC
| ATTEROCOR, INC.
| SEMNUR PHARMACEUTICALS, INC.
| PRONAI THERAPEUTICS INC
| ALLENA PHARMACEUTICALS, INC.
| CHANRX CORP.
| ANAPTYSBIO INC
| LAGUNA PHARMACEUTICALS, INC.
| ALPINE IMMUNE SCIENCES, INC.
| MERGANSER BIOTECH, INC.
| ALCRESTA, INC.
| ALCRESTA THERAPEUTICS, INC.
| MILLENDO THERAPEUTICS, INC.
| APTINYX INC.
| ALPINE IMMUNE SCIENCES, INC.
| AMUNIX PHARMACEUTICALS, INC.
| ENLAZA THERAPEUTICS, INC.
JAMES
N.
TOPPER
DIRECTOR
ALNARA PHARMACEUTICALS INC
| ANAPTYSBIO INC
| AMICUS THERAPEUTICS INC
| FRAZIER HEALTHCARE VII-A, L.P.
| FRAZIER HEALTHCARE VII, L.P.
| FRAZIER LIFE SCIENCES VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES VIII, L.P.
| APTINYX INC.
| FRAZIER LIFE SCIENCES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX PV, L.P.
| SERAXIS HOLDINGS, INC.
| FRAZIER LIFE SCIENCES XI, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-07-13
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

